Grants & Programs


- See more at:

Immunotherapy: Combine and Conquer
Nature Medicine
May 7, 2015

“Launched in 2012, [the Cancer Research Institute’s] Clinical Accelerator assembled a network of 60 leading academic immunotherapy researchers who select innovative combinations on the basis of preclinical and other data….So far, 11 announced company partners are providing access to more than 30 drugs speaking to the success of this effort.”

CRI and Cancer Immunology
April 27, 2015

“By breaking down the natural competitive silos that tend to slow progress, the Clinical Accelerator helps bring better immunotherapies to patients more quickly.”

Ludwig Cancer Research and Cancer Research Institute Collaborate on Evaluation of VentiRx's Investigational Immunotherapy
Cancer Research Institute
September 3, 2014

Fresh funds in hand, VentriRx joins AstraZeneca, Ludwig and CRI for combo immuno-oncology study
Fierce Biotech
September 3, 2014

Immunotherapy in the Fast Lane: CRI's Clinical Accelerator Takes Off
Cancer Research Institute
January 7, 2014

Innovator Spotlight: Cancer Research Institute
FasterCures TRAIN Central Station
November 2013

“Our Clinical Accelerator represents the fulfillment of our organization’s ultimate goal to bring lifesaving immunotherapies to cancer patients.” – Jill O’Donnell-Tormey, Ph.D., CEO and Director of Scientific Affairs, Cancer Research Institute

Combining Different Cancer Treatments to Maximize Patient Results
Cancer Research Institute
October 21, 2013

A Unique Approach to Translational Research
Cancer Research Institute
September 10, 2013

A Unique Approach to Translational Research